{"name":"MedPacto, Inc.","slug":"medpacto-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizAJBVV95cUxOa3M0UlRnRDJDclo5c0lDYXd0MVNTSkpTZmNOUkl3MDEyZEk4anRzallJSzBfb2R0a28wRnFoVWYyM2tNVVEyS0tVNWczY1RXSWl0Q0JQeVZBNmRZNzJYZk5FRC16cUFvQWxXV0tSaXJfUE8xTElyRDc0SXJ4QkppY3JINVpQVURrM2dJcnVjVjdGQnp6M3NyUmctXzczbTVDNk5pbEhSeWQzelBTQ2dyb3VwZG8tbWtIV1JJUTg1aURZM0d6VXo3YzNrNm03a2IxazFDQ2JqSm0yNWVXU1dySnpKUG5iekFyalFYNDl2TE5sZXRBSWt5aDQyZFhaOUx0cXRvYk5JbXI5bmVGU1JsTkhmU2ZNbjJxNFNIVE1JUndiQ2g4aXZHaXVMSE1acjFDQVFXYThTOWFJNjBtWlZHQVVGRG5lWHJQcERaRQ?oc=5","date":"2026-03-31","type":"trial","source":"Barchart","summary":"Urothelial Carcinoma Clinical Trial Pipeline Expands as 40+ Pharma Companies Progress 50+ Novel Therapies Toward Market Entry, Finds DelveInsight | Janssen Research and Development, MedPacto - Barchar","headline":"Urothelial Carcinoma Clinical Trial Pipeline Expands as 40+ Pharma Companies Progress 50+ Novel Therapies Toward Market ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxOSjRYSHNzbkE2WjJUM0U5cmxwdktHblROd0hoeFlhaWd3RHBXMXdHYTFVWkl3U0ROQnBtRWZleFcwUXg0T2QycVFwUUJrRlVnNGpkQlBYdlY4bndsd2FubjJ0aUgyQ19IQUJWSWRrcGRVbUVTX3FEOUdjVFR4WUFFNmNzWmV3cHk2MTB0eDFwdmV0a09tZnRDaFBoU3pVRVdWeldrQm9nNnY3YmljSmJndE5mWjc3d0YtUjV4WmNJSE9MaVhqWFBic1NBYTVsX0kzSXBGbEFmV0lESU5ON18tU1NpMlFZanBjZkJtbTZaOHlyRTc3VVR4UVFIRUZscThDTzBPQmNtd2l1cTRfdkUyOG1DZWJTQ2N2TFhiMjRnWml6MWVjYW5GeDFydXZicC0xeVRFMVh4QzBudw?oc=5","date":"2026-03-30","type":"trial","source":"Mena FN","summary":"Urothelial Carcinoma Clinical Trial Pipeline Expands As 40+ Pharma Companies Progress 50+ Novel Therapies Toward Market Entry, Finds Delveinsight Janssen Research And Development, Medpacto - Mena FN","headline":"Urothelial Carcinoma Clinical Trial Pipeline Expands As 40+ Pharma Companies Progress 50+ Novel Therapies Toward Market ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1OY3NZTzZkZkFPeTFWakxFYkExMXBHQkxJMHppM1U4QWp4ZXZ2SVBxQnE0ZkZjRlBWbnFEWUloOWFVVzY1ZmRJTG5qMnNEbzF6a0swSU03WGVkeXBkYWx5X3NMRVh0eWw4TkY4OVh30gFyQVVfeXFMTUxrNlFkdEJmdHJvZWl6enZCZUszZ0lxQm10QjJuRTZ2VzlTVXNERTVxOU9PZjhrcWdFOU1pVWdKbUtrTzZuYVd0cFRhUFdmb01VcVpMU2JuSjJKUmM5ejl4SlJJRHNHUjNXREFjOWJtNzVn?oc=5","date":"2025-09-01","type":"trial","source":"koreabiomed.com","summary":"MedPacto begins phase 2 trial of vactosertib in osteosarcoma patients in Korea, US - koreabiomed.com","headline":"MedPacto begins phase 2 trial of vactosertib in osteosarcoma patients in Korea, US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE40YmxrbkJpdGJ3bGV2TWRtYlNfVzBTZmt3WVpnclFlM2ptMmVSTHA5T2ozVTZlejljek9UbWRUelFDT0FxR21OdVB5RHYyaVNfZGd5MGVQbElpNHJ2ZkN6VEVDbHdZZEJDVzh1eFRn0gFyQVVfeXFMT0xxYXVUMXhlNHROaHQxdHdhLU9YdjZxc2pPREI2THBxenNKZ3h1U1doUlIzamhLQmdJUmxScDV0aVptallicldtVjlNNktkVEFtUVhEdV9YZFY2dmF6VXJpMkd1VmljUDVRUTdpSDFpQWdR?oc=5","date":"2023-12-07","type":"pipeline","source":"koreabiomed.com","summary":"KDDF selects 4 companies for Korea's national new drug development project - koreabiomed.com","headline":"KDDF selects 4 companies for Korea's national new drug development project","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9Vd2VJRFBxQUg3QWVtZFdWQm5vQzhvUVNpREhfdDE3ZlkybjYwb1dDQXFNQVFsR3Y1aERicHEtaDVTTVBRMkVLOTBFMTdaZzlRbGN0eWdNTnY2a3JDMHMxcTM5UzhTUmpxZ0hUZ1hn0gFyQVVfeXFMT0JFMVJyOUlMSkJQNVhRRE5tWkpSWHZtNDRaUHdVVUtjUWFZQlhMa1VfelNaZU91MG9WaGxhU191R0dQNllyVmFYTnlWbFJLdUhTMEk2Tks5ZFl1QTctX2xZZjNvMFV4cVpNZmV0V3hFb01R?oc=5","date":"2023-07-27","type":"regulatory","source":"koreabiomed.com","summary":"MedPacto’s osteosarcoma drug vactosertib wins EMA’s orphan drug designation - koreabiomed.com","headline":"MedPacto’s osteosarcoma drug vactosertib wins EMA’s orphan drug designation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5UazlnUEI5UENVb0RvTXRhdVZ5U2pZOC1oMnB6U2VlY3lfM0R3NldCZnItYnR4Q29MSmFpZGt3SXR4Sm00QmRaLUx5bHhvMDNMNkExejZMeTFiZFdyX0U5c2VuV05MZjBkSHE0UXVB0gFyQVVfeXFMUFRTUGt6djNXU1BUQThNMTJ6S3lZZmxCc2J5NFh3c1ZzMlJ4MGZRUjhWalBfZDJYcjcyM0lfUmhoNEk3emhkUFEzSnBIRGZJUTI1REI4dDBPQWdGSFFnN0FBdXNVU2dobjNLZFloMU5VUGFn?oc=5","date":"2021-01-08","type":"pipeline","source":"koreabiomed.com","summary":"Korean drugmakers to present strategies at annual JP Morgan Healthcare Conference - koreabiomed.com","headline":"Korean drugmakers to present strategies at annual JP Morgan Healthcare Conference","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}